Fundraising Fox
/People
Sign in

Mary Tagliaferri

Board director at Iambic

San Francisco Bay Area

Find your path to Mary

392 people in our graph can introduce you to Mary.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jonathan Leff to introduce you to Mary

You →Jonathan · together at InterMune (2014) →Mary

Ask Jamie Chen to introduce you to Mary

You →Jamie · 2 people · together at InterMune →Mary

Ask Sam Okafor to introduce you to Mary

You →Sam · 3 people · together at Iambic →Mary

Sign up to find every way you can get introduced to Mary

  • Your email: the people you already email who know Mary
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Mary
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Mary Tagliaferri has 30 years of experience in the life sciences industry, with a focus on oncology and immunology drug development, clinical trials, drug safety, and regulatory affairs. She has served as Chief Medical Officer at three companies, including Nektar, overseeing clinical development, regulatory submissions, business development, fundraising, and investor relations. She is an independent board member at ADARx Pharmaceuticals Inc. and has held board positions at other public and private biotechnology companies.

Board director at Iambic

Intro paths

→

In turn, Mary can intro founders to Iambic's investors below.

Iambic's investors · 14

AbingworthLondon · $15M – $30M checks · since 2023Alumni VenturesManchester · $100K – $10M checksAscenta CapitalWilmington · $15M – $30M checksCatalio Capital ManagementNew YorkCatalio Capital Management, LPNew YorkCoatue ManagementNew York · $1M – $20M checksEisai Innovation, Inc.Cambridge · $5M checksFREEFLOWBerkeleyIllumina VenturesFoster CityIreland Strategic Investment FundDublinNexus Venture PartnersMenlo Park · $500K – $10M checks · since 2023NVIDIASanta Clara · since 2024OrbiMedNew York · $1M – $75M checksSequoia CapitalMenlo Park · $100K – $50M checks

Co-founders at Iambic

TMTom Miller
Tom MillerCo-Founder & CEO
FM
Fred ManbyCo-Founder & CTO

Experience

  1. ADARx Pharmaceuticals Inc.Independent Board Membercurrent2025 — present
  2. Nektar TherapeuticsSenior Vice President, Chief Medical Officercurrent2025 — present
  3. Iambic TherapeuticsIndependent Board Membercurrent2024 — presentSan Diego Metropolitan Area
  4. Y-mAbs Therapeutics, Inc.Independent Board Member2024 — 2025New York, New York, United States
  5. Nektar TherapeuticsSenior Vice President, Chief Medical/Development Officer2022 — 2025San Francisco, California, United States
  6. Nektar TherapeuticsSenior Vice President, Executive Clinical Fellow2020 — 2022United States
  7. Nektar TherapeuticsSenior Vice President, Chief Medical Officer2017 — 2020San Francisco Bay Area
  8. Nektar TherapeuticsSenior Vice President, Clinical Development2017San Francisco, California
  9. Nektar TherapeuticsVice President, Clinical Development2015 — 2017San Francisco, California
  10. ChiefFounding Member2020 — 2024San Francisco Bay Area
  11. Enzo Biochem IncIndependent Board Member2020 — 2024New York City Metropolitan Area
  12. RayzeBioIndependent Board Member2021 — 2024San Diego, California, United States
  13. InterMuneConsultant-Project Team Lead: Expanded Access Program2014Brisbane, California
  14. KanglaiteChief Medical Officer2012 — 2014
  15. Bionovo, Inc.Co-Founder, President, Chief Medical Officer, Chief Regulatory Officer2002 — 2012Emeryville, CA

Skills & more

Biotechnology36Pharmaceutical Industry80Oncology60FDA38Clinical Trials43Clinical Development52Molecular Biology4Clinical Research28Technology Transfer8Regulatory Affairs16Lifesciences6Biopharmaceuticals9
+8 moreDrug DiscoveryRegulatory SubmissionsCancerDrug DevelopmentMedicineCROPharmacologyImmunology

Languages Spanish

From Mary's professional profile.

Frequently asked questions

Who is Mary Tagliaferri?
Mary Tagliaferri has 30 years of experience in the life sciences industry, with a focus on oncology and immunology drug development, clinical trials, drug safety, and regulatory affairs. She has served as Chief Medical Officer at three companies, including Nektar, overseeing clinical development, regulatory submissions, business development, fundraising, and investor relations. She is an independent board member at ADARx Pharmaceuticals Inc. and has held board positions at other public and private biotechnology companies.
Where does Mary Tagliaferri work?
Mary Tagliaferri is Board director at Iambic.
Where did Mary Tagliaferri go to school?
Mary Tagliaferri studied at University of California, San Francisco (MD, Medicine); American College of Traditional Chinese Medicine (LAc, Master of Science, Oriental Medicine); Cornell University (Bachelor of Science (BS), Bachelor of Science, Agricultural Economics and Business Management).

Same school

Shared employers